Gamida Cell Reports Full Year 2022 Financial Results and Pro

Company reports on productive interactions with FDA and preparations for launch of omidubicel, if approved, in advance of May 1 PDUFA date

Company outlines strategic restructuring, plans to... | March 27, 2023

Related Keywords

United States , Jerusalem , Israel General , Israel , Kiryat Gat , Hadarom , American , Israeli , Shawn Cline Tomasello , Roberti Blum , Veronika Bachanova , Abbey Jenkins , Naama Halevi Davidov , Exchange Commission , University Of Minnesota Medical School , International Blood , Nasdaq , Twitter , Israeli Innovation Authority , Access Program , Gamida Cell Ltd , Highbridge Capital Management , Marrow Transplant Research , Israeli Ministry Of Health , Gamida Cell , Prescription Drug User Fee Act , Chief Executive Officer , Late Cycle Meeting , Pre Licensing Inspection , Advanced Cell , Cellular Therapy , American Society , Extended Access Program , Israeli Ministry , Tandem Meetings , Minnesota Medical School , Chairman Robert , Gamida Cell Board , Anat Cohen Dayag , Breakthrough Therapy Designation , Orphan Drug Designation , Private Securities Litigation Reform Act , Risk Factors , Quarterly Report , Gamida Cell Ltd Stock Exchange , News , Information , Press Release , Company , Reports , N , Productive , Interactions , Ith , Fda , End , Preparations , Or , Launch , F , Advance , Bay , , Pdufa , Outlines , Strategic , Lans Gmda Il0011552663 ,